Lactate dehydrogenase as a marker for testicular germ-cell tumours.

[1]  W. Bodmer,et al.  Monoclonal antibody assay of serum placental alkaline phosphatase in the monitoring of testicular tumours. , 1985, British Journal of Cancer.

[2]  A. Horwich,et al.  Serum tumour marker regression rate following chemotherapy for malignant teratoma. , 1984, European journal of cancer & clinical oncology.

[3]  W. Fishman,et al.  Placental alkaline phosphatase as a tumor marker for seminoma. , 1982, Cancer research.

[4]  N. Javadpour,et al.  Lactic dehydrogenase in the monitoring and prognosis of testicular cancer , 1981, Cancer.

[5]  N. Javadpour,et al.  Role of lactate dehydrogenase isoenzymes in testicular cancer. , 1981, Urology.

[6]  A. Barrett,et al.  Non-seminoma germ cell tumours (malignant teratoma) of the testis. Results of treatment and an analysis of prognostic factors. , 1981, British journal of urology.

[7]  M. Peckham.  The Management of testicular tumours , 1981 .

[8]  D. Skinner,et al.  Significance of serum lactic dehydrogenase in stages B and C non-seminomatous testis tumors. , 1980, The Journal of urology.

[9]  T. Waldmann,et al.  Human chorionic gonadotropin (HCG) and alpha‐fetoprotein (AFP) in sera and tumor cells of patients with testicular seminoma. A prospective study , 1978, Cancer.

[10]  F. V. Eyben.  Biochemical markers in advanced testicular tumors. Serum lactate dehydrogenase, urinary chorionic gonadotropin and total urinary estrogens , 1978, Cancer.

[11]  Lange Ph,et al.  Serum alpha-fetoprotein and human chorionic gonadotropin in the treatment of patients with testicular tumors. , 1977 .

[12]  T. Aoki.  [Lactic dehydrogenase (LDH)]. , 1967, Nihon rinsho. Japanese journal of clinical medicine.